The selected novel radiotracer [68Ga]Ga-PSMA-Q exhibited fairly high accumulation in PSMA+ tumors and satisfying pharmacokinetic characteristics, resulting in great potential for PCa tumor detection. This evidence concerns the gene FOLH1 and neoplasm.